Roth JA - Search Results

1

PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non-Small Cell Lung Cancer.

Negrao MV, Lam VK, Reuben A, Rubin ML, Landry LL, Roarty EB, Rinsurongkawong W, Lewis J, Roth JA, Swisher SG, Gibbons DL, Wistuba II, Papadimitrakopoulou V, Glisson BS, Blumenschein GR Jr, Lee JJ, Heymach JV, Zhang J. Negrao MV, et al. Among authors: roth ja. J Thorac Oncol. 2019 Jun;14(6):1021-1031. doi: 10.1016/j.jtho.2019.02.008. Epub 2019 Feb 16. J Thorac Oncol. 2019. PMID: 30780001 Free article.

2

Combination immunotherapy for advanced lung cancer.

Yang SC, Grimm EA, Roth JA. Yang SC, et al. Among authors: roth ja. J Natl Cancer Inst Monogr. 1992;(13):197-201. J Natl Cancer Inst Monogr. 1992. PMID: 1327033 Clinical Trial.

3

New approaches to treating early lung cancer.

Roth JA. Roth JA. Cancer Res. 1992 May 1;52(9 Suppl):2652s-2657s. Cancer Res. 1992. PMID: 1562995 Review.

4

Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial.

Yang SC, Grimm EA, Parkinson DR, Carinhas J, Fry KD, Mendiguren-Rodriguez A, Licciardello J, Owen-Schaub LB, Hong WK, Roth JA. Yang SC, et al. Among authors: roth ja. Cancer Res. 1991 Jul 15;51(14):3669-76. Cancer Res. 1991. PMID: 1648441 Clinical Trial.

5

Resectability of small-cell lung cancer following induction chemotherapy in patients with limited disease (stage II-IIIb).

Zatopek NK, Holoye PY, Ellerbroek NA, Hong WK, Roth JA, Ryan MB, Komaki R, Pang AC, Glisson BS. Zatopek NK, et al. Among authors: roth ja. Am J Clin Oncol. 1991 Oct;14(5):427-32. doi: 10.1097/00000421-199110000-00013. Am J Clin Oncol. 1991. PMID: 1659177

6

Radiation therapy following resection of non-small cell bronchogenic carcinoma.

Slater JD, Ellerbroek NA, Barkley HT Jr, Mountain C, Oswald MJ, Roth JA, Peters LJ. Slater JD, et al. Among authors: roth ja. Int J Radiat Oncol Biol Phys. 1991 May;20(5):945-51. doi: 10.1016/0360-3016(91)90190-f. Int J Radiat Oncol Biol Phys. 1991. PMID: 1850721

7

Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha.

Yang SC, Owen-Schaub L, Mendiguren-Rodriguez A, Grimm EA, Hong WK, Roth JA. Yang SC, et al. Among authors: roth ja. J Thorac Cardiovasc Surg. 1990 Jan;99(1):8-12; discussion 12-3. J Thorac Cardiovasc Surg. 1990. PMID: 2152954

8

Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.

Schneider PM, Hung MC, Chiocca SM, Manning J, Zhao XY, Fang K, Roth JA. Schneider PM, et al. Among authors: roth ja. Cancer Res. 1989 Sep 15;49(18):4968-71. Cancer Res. 1989. PMID: 2569928

9

Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector.

Jin X, Nguyen D, Zhang WW, Kyritsis AP, Roth JA. Jin X, et al. Among authors: roth ja. Cancer Res. 1995 Aug 1;55(15):3250-3. Cancer Res. 1995. PMID: 7614457

10

Survival in early-stage non-small cell lung cancer.

Nesbitt JC, Putnam JB Jr, Walsh GL, Roth JA, Mountain CF. Nesbitt JC, et al. Among authors: roth ja. Ann Thorac Surg. 1995 Aug;60(2):466-72. doi: 10.1016/0003-4975(95)00169-l. Ann Thorac Surg. 1995. PMID: 7646126 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,250 results

Search Page

Filters